Search hospitals > Louisiana > Metairie
East Jefferson General Hospital
Claim this profileMetairie, Louisiana 70006
Global Leader in Oral Cancers
Global Leader in Prostate Cancer
Conducts research for Kidney Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
93 reported clinical trials
11 medical researchers
Summary
East Jefferson General Hospital is a medical facility located in Metairie, Louisiana. This center is recognized for care of Oral Cancers, Prostate Cancer, Kidney Cancer, Lung Cancer, Cancer and other specialties. East Jefferson General Hospital is involved with conducting 93 clinical trials across 239 conditions. There are 11 research doctors associated with this hospital, such as Scott E. Delacroix, Brian C. Boulmay, Augusto C. Ochoa, and Agustin Garcia, M.D..Area of expertise
1Oral Cancers
Global LeaderStage IV
Stage II
Stage I
2Prostate Cancer
Global LeaderStage IV
PD-L1 positive
hCG positive
Top PIs
Scott E. DelacroixLSU Healthcare Network / Metairie Multi-Specialty Clinic2 years of reported clinical research
Expert in Prostate Cancer
Expert in Oral Cancers
28 reported clinical trials
63 drugs studied
Brian C. BoulmayUniversity Medical Center New Orleans4 years of reported clinical research
Studies Lung Cancer
Studies Oral Cancers
18 reported clinical trials
30 drugs studied
Augusto C. OchoaGulfport Memorial Hospital7 years of reported clinical research
Expert in Cancer
Studies Breast cancer
16 reported clinical trials
71 drugs studied
Agustin Garcia, M.D.University Medical Center New Orleans8 years of reported clinical research
Studies Cancer
Studies Breast Cancer
9 reported clinical trials
18 drugs studied
Clinical Trials running at East Jefferson General Hospital
Prostate Cancer
Bladder Cancer
Kidney Cancer
Breast Cancer
Lung Cancer
Oral Cancers
Bladder Carcinoma
Ovarian Cancer
Breast cancer
Renal Cell Carcinoma
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at East Jefferson General Hospital?
East Jefferson General Hospital is a medical facility located in Metairie, Louisiana. This center is recognized for care of Oral Cancers, Prostate Cancer, Kidney Cancer, Lung Cancer, Cancer and other specialties. East Jefferson General Hospital is involved with conducting 93 clinical trials across 239 conditions. There are 11 research doctors associated with this hospital, such as Scott E. Delacroix, Brian C. Boulmay, Augusto C. Ochoa, and Agustin Garcia, M.D..